ASCO Breakthrough is an annual Asia-Pacific oncology meeting that brings together global experts to share novel research and multidisciplinary perspectives on the latest scientific discoveries, clinical advances, and emerging treatment approaches transforming cancer care. This year, ASCO Breakthrough 2026 is bringing together the global oncology community in Singapore and online from June 25–27 for three days of high-impact scientific and educational sessions, case-based discussions, and abstract presentations, fostering collaboration and knowledge exchange to advance cancer care worldwide.
Yan Leyfman, Medical Oncologist, Co-Founder and Executive Director of MedNews Week, shares key insights and highlights from ASCO Breakthrough 2026:
Outstanding presentation by Dr. Francesca Lim
“Outstanding presentation by Dr. Francesca Lim at the 2026 ASCO Breakthrough Annual Meeting highlighting the latest advances in CAR T-cell therapy and the opportunities that lie ahead.
Dr. Lim delivered an excellent overview of the remarkable progress CAR T-cell therapy has made while thoughtfully addressing the significant challenges that remain—particularly in T-cell lymphomas, where unique biologic and manufacturing hurdles continue to drive innovation. Her discussion provided valuable perspective on where the field stands today and the exciting directions that may shape its future.
A fantastic presentation filled with insightful discussion from a leader helping advance the next generation of cellular therapies.”
ADCs in Lung Cancer Dr David R Gandara ASCO Breakthrough 2026
“Outstanding “Tour de France” through the evolving landscape of antibody-drug conjugates (ADCs) in lung cancer by Dr. David R. Gandara at the 2026 ASCO Breakthrough Annual Meeting.
From the rapid evolution of ADCs to where the field is headed next, Dr. Gandara delivered an exceptional overview of one of the most exciting areas in thoracic oncology. The audience greatly appreciated his thoughtful commentary, clinical insights, and vision for the future.
Privileged to learn from a true global leader who continues to help shape the future of lung cancer care.”
Global ADC Ecosystem Dr Lillian L Siu ASCO Breakthrough 2026
“An outstanding presentation on the global antibody-drug conjugate (ADC) ecosystem by Dr. Lillian L. Siu at the 2026 ASCO Breakthrough Annual Meeting.
Dr. Siu provided a comprehensive perspective on the rapidly expanding ADC landscape—from scientific innovation and clinical development to the collaborative ecosystem driving the next generation of targeted therapies. Her insights highlighted both the remarkable progress achieved and the exciting opportunities that lie ahead across tumor types.
A privilege to learn from one of oncology’s foremost leaders whose vision continues to shape the future of precision cancer therapeutics.”
Immunotherapy in Colorectal Cancer: Dr Gwo Fuang Ho ASCO Breakthrough 2026
“Eloquent review of the latest promising targeted immunotherapy clinical trials for colorectal cancer by Dr Gwo Fuang Ho at 2026 ASCO Breakthrough Annual.”
Cancer Incidence in Asia and ctDNA Dr Herbert Loong ASCO Breakthrough 2026
“Great overview of incidence of cancers within Asia as well at the latest developments in ctDNA and early diagnostics from Dr Herbert Loong at ASCO Breakthrough.”
DLBCL Treatment Landscape: Dr Bor-Sheng Ko ASCO Breakthrough 2026
“One of the highlights of the meeting was Dr. Bor-Sheng Ko‘s outstanding session on the rapidly evolving treatment landscape for diffuse large B-cell lymphoma (DLBCL) at the 2026 ASCO Breakthrough Annual Meeting.
Dr. Ko seamlessly connected today’s evidence-based practice with tomorrow’s innovations, providing a clear roadmap of where DLBCL management is headed. From advances in immunotherapy and cellular therapy to emerging targeted strategies, the session captured both the progress already achieved and the exciting possibilities on the horizon.
An engaging and insightful presentation that left the audience with a deeper appreciation of how innovation is continuing to redefine lymphoma care.”
Confronting the Global Surge of Early-Onset Cancers
“An insightful session hosted by Dr Kimmie Ng about Young and Diagnosed: Confronting the Global Surge of Early-Onset Cancers filled with great speakers, insight and approaches to combat global inequities at the 2026 ASCO Breakthrough Meeting.”
Stay tuned with OncoDaily for updates from ASCO Breakthrough 2026.
